Clinical Trial

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluate the association of body composition (mainly free-fat mass), clinical and biochemical parameters with development of toxicity in patients under treatment with Carboplatin/Paclitaxel in advanced NSCLC.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2016-04-05; most recent amendment 2025-12-17.
Trial Details
NCT Number NCT02734069
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions Lung Cancer, Sarcopenia, Toxicity
Enrollment 132 participants
Start Date 2016-02
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-24